Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients
Alpana Waghmare(Seattle Children's Hospital), Zainab Shahid(Memorial Sloan Kettering Cancer Center), Michael Boeckh(Fred Hutch Cancer Center), Sanjeet Dadwal(City Of Hope National Medical Center), Steven A. Pergam(Seattle Cancer Care Alliance), Roy F. Chemaly(The University of Texas MD Anderson Cancer Center), Genovefa A. Papanicolaou(Memorial Sloan Kettering Cancer Center), Maheen Z. Abidi(University of Colorado Denver), Mini Kamboj(Memorial Sloan Kettering Cancer Center), Zeinab El Boghdadly(The Ohio State University Wexner Medical Center)
Cited by 65
Related Papers
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
|Biology of Blood and Marrow Transplantation|2009|1.8k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k